ACM
MDXH icon

Altium Capital Management’s MDxHealth MDXH Stock Holding History

Altium Capital Management’s Portfolio MDXH Stock Details MDXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-36,159
Closed -$344K – 143
2021
Q4 		$344K Buy
+36,159
New +$354K 0.09% 108

Other funds holding MDXH

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
MPU
MVM Partners (UK) London, United Kingdom $149M AUM 6.81% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Altium Capital Management's MDXH Position: Q1 2022 in Review

Altium Capital Management sold out of MDxHealth (MDXH) in Q1 2022, closing a stake of 36,159 shares — an estimated $344K sold.

Altium Capital Management first reported a position in MDXH in Q4 2021 and held it in 1 quarter. The position peaked at $344K in Q4 2021. 5 funds tracked by Wall St. Rank hold MDXH as of Q1 2022.

  • Altium Capital Management reported no remaining MDxHealth position as of Q1 2022 after selling out during the quarter.
  • Altium Capital Management sold 36,159 MDxHealth shares in Q1 2022, an estimated $344K.
  • Altium Capital Management first reported a position in MDxHealth in Q4 2021 and held it in 1 quarter.
  • Altium Capital Management's MDxHealth position peaked at $344K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held MDxHealth as of Q1 2022.

Based on Altium Capital Management's 13F filing for Q1 2022, filed 16 May 2022.